Q2 2026 Holdings
Filed 2026-08-14 | 36 holdings | $580.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lakefront Biotherapeutics NV(GLPG) | SPON ADR | 36315X101 | $61.3M | 2,043,344 | 10.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $58.4M | 3,804,481 | 10.1% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $56.5M | 810,000 | 9.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $54.2M | 1,270,273 | 9.3% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $41.3M | 5,957,877 | 7.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $40.0M | 375,609 | 6.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.5M | 98,080 | 5.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $26.2M | 1,200,000 | 4.5% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $22.2M | 2,021,964 | 3.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $20.7M | 394,389 | 3.6% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $19.7M | 165,500 | 3.4% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $18.8M | 106,200 | 3.2% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $17.6M | 674,434 | 3.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $14.3M | 107,394 | 2.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $14.0M | 374,666 | 2.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $12.1M | 449,795 | 2.1% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $8.4M | 7,824,749 | 1.4% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $7.5M | 51,000 | 1.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $6.8M | 17,000 | 1.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $6.1M | 650,000 | 1.1% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $6.1M | 268,269 | 1.0% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $5.9M | 85,500 | 1.0% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $5.7M | 270,716 | 1.0% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $4.5M | 978,992 | 0.8% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $3.9M | 459,952 | 0.7% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.3M | 135,366 | 0.6% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $3.0M | 157,500 | 0.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.4M | 700,000 | 0.4% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.3M | 474,638 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.6M | 1,370,233 | 0.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.4M | 39,731 | 0.2% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $1.2M | 90,000 | 0.2% |
| Everforth Inc(ASGN) | COM | 00191U102 | $1.2M | 67,500 | 0.2% |
| Rein Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $1.1M | 1,100,000 | 0.2% |
| Coya Therapeutics Inc(COYA) | COMMON STOCK | 22407B108 | $994.5K | 170,000 | 0.2% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $183.9K | 36,861 | 0.0% |